Cancer Biomarkers Market , Share, Trends and Forecast Analysis 2035
According to Payal Rabde, who specializes in the identification of unique molecular traits, genetic changes in cancer patients, and biological signals to detect, diagnose, and guide the patient for the treatment of cancer, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the cancer biomarkers market. The global cancer biomarkers market size was estimated at USD 38.62 billion in 2025 and is predicted to increase from USD 43.54 billion in 2026 to approximately USD 128 billion by 2035, expanding at a CAGR of 12.73% from 2026 to 2035. The market is growing due to increasing global cancer cases, precision oncology, rising investment in various pharmaceutical and biotechnology firms for investing in biomarker-driven clinical trials, and innovation in next-generation sequencing.
Last Updated : 31 August 2026
Category: Diagnostics
Insight Code: 5335
Format: PDF / PPT / Excel